# Haloperidol decanoate

NDC: 68001-658
Generic name: Haloperidol decanoate
Labeler / Manufacturer: BluePoint Laboratories
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR
Marketing started: 20250612

FDA application: ANDA211180

## Active ingredients

- HALOPERIDOL DECANOATE: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68001-658"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68001-658
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d011250-a517-4c27-8ce3-d59d441ea61c